Uneingeschränkter Zugang

Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment


Zitieren

1. Hsiao MC, Hsiao CC, Liu C. Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders. Psychiatry Clin Neurosci 2004; 58: 186-190.10.1111/j.1440-1819.2003.01215.x Search in Google Scholar

2. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 2003; (Suppl 3): S55.10.1016/S0306-4530(03)00097-0 Search in Google Scholar

3. Vladimirova R. Specific mental health problems in women. Bulgarska nevrologichna i psikhiatrichna praktika 2004a; 3: 28-9. Search in Google Scholar

4. Lasiuk G, Hegadoren K. The effects of estradiol on central serotonergic systems and its relationship to mood in women. Biological Research for Nursing 2007; 9(2): 147-160.10.1177/109980040730560017909167 Search in Google Scholar

5. N-Wihlback A-C, Sundstrom-Poromaa I, Backstrom T. Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology 2006; 186(6): 388-401.10.1007/s00213-005-0185-216362406 Search in Google Scholar

6. Vladimirova R. Depression and pregnancy. Bulgarska nevrologichna i psikhiatrichna praktika 2004b; 1: 17. Search in Google Scholar

7. Chaudron L, Klein M, Remington P et al. Predictors, prodromes and incidence of postpartum depression. J Psycho-som Obstet Gynecol 2001; 22(2): 103-112.10.3109/0167482010904996011446151 Search in Google Scholar

8. Freeman E, Sammel M, Rinaudo P, Sheng L. Premenstrual syndrome as a predictor of menopausal symptoms. Obstet Gynaecol 2004; 103: 960-966.10.1097/01.AOG.0000124804.81095.7f15121571 Search in Google Scholar

9. Critchlow D, Bond AJ, Wingrove J. Mood disorder history and personality assessment in premenstrual dysphoric disorder. J Clin Psychiatry 2001; 62(9): 688-693.10.4088/JCP.v62n090511681764 Search in Google Scholar

10. Wilson A, Henry DA. Meta-analysis Part 2 assessing the quality of published meta-analyses. Med J Aust 1992; 156(3): 173-187.10.5694/j.1326-5377.1992.tb139704.x Search in Google Scholar

11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author. 2013.10.1176/appi.books.9780890425596 Search in Google Scholar

12. Ito M, Matubara R. Premenstrual syndrome in women with mood and anxiety disorder. Clin Psychiatry 2006; 48: 750-763. Search in Google Scholar

13. Kim D, Gyulai L, Freeman E et al. Premenstrual dysphoric disorder and psychiatric comorbidity. Archives of Women’s Mental Health 2004; 7: 37-47.10.1007/s00737-003-0027-314963731 Search in Google Scholar

14. Miyaoka Y, Akimoto Y, Ueda K et al. Fulfilment of the premenstrual dysphoric disorder criteria confirmed using self-rating questionnaire among Japanese women with depressive disorders. BioPsychoSocial Medicine 2011; 5: 5.10.1186/1751-0759-5-5 Search in Google Scholar

15. Cohen LS, Soares CN, Otto MW et al. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord 2002; 70: 125-132.10.1016/S0165-0327(01)00458-X Search in Google Scholar

16. Soares C, Cohen L, Harlow MO. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. Journal of Women’s Health and Gender Based Medicine 2001; 10(9): 873-878.10.1089/152460901753285778 Search in Google Scholar

17. Adewuya A, Loto O, Adewumi T. Premenstrual dysphoric disorder amongst Nigerian university students: prevalence, comorbid conditions, and correlates. Archives of Women’s Mental Health 2008; 11(1): 13-18.10.1007/s00737-008-0213-4 Search in Google Scholar

18. Choudhari S, Rajshri, Inamdar S et al. A study of co-morbid depression and anxiety in pre-menstrual dysphoric disorder (PMDD) among undergraduate medical students: a descriptive study. Medica innovatica 2017; 6(1): 13-18. Search in Google Scholar

19. Forrester-Knauss C, Stutz EZ, Weiss C, Tschudin S. The interrelation between premenstrual syndrome and major depression: Results from a population-based sample. BMC Public Health [Internet] 2011 Oct [cited 2018 Jun 28]; 11: 795. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209462/.10.1186/1471-2458-11-795 Search in Google Scholar

20. Treloar S, Heath A, Martin N. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychol Med 2002; 32(1): 25-38.10.1017/S0033291701004901 Search in Google Scholar

21. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini International Neuropsychiatric Interview (M.I.N.I.): The development and validation of structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; Suppl 20: S22. Search in Google Scholar

22. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003; 6(3): 203-209.10.1007/s00737-003-0018-4 Search in Google Scholar

23. Clare A. Psychiatric and social aspects of premenstrual complaint. Psychological Medicine. Monograph Supplement 1983; 4: 1-58. Search in Google Scholar

24. Siegel JP, Meyers B, Dineen MK. Comparison of depressed and nondepressed women with severe Premenstrual Tension Syndrome. Psychother Psychosom 1986; 45: 113-117.10.1159/000287936 Search in Google Scholar

25. Richards M, Rubinow DR, Daly RC, Schmidt PJ. Premenstrual symptoms and perimenopausal depression. Am J Psychiatry 2006; 163: 133-137.10.1176/appi.ajp.163.1.133 Search in Google Scholar

26. Marjoribanks J, Brown J, O’Brien PMS, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews [Internet] 2013 [cited 2018 Jul 10];7(6). Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001396.pub3/pdf. Search in Google Scholar

27. Dimmock PW, Wyatt KM, Jones PW, O’Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000; 356: 1131-1136.10.1016/S0140-6736(00)02754-9 Search in Google Scholar

28. Ismaili E, Walsh S, O’Brien PMS et al. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health 2016; 19: 953-958.10.1007/s00737-016-0631-727378473 Search in Google Scholar

29. Halbreich U, O’Brien P, Eriksson E et al. Are there differential symptom profiles that improve in response to different pharmacological treatments of Premenstrual Syndrome/Premenstrual Dysphoric Disorder? CNS Drugs 2006; 20(7): 523-547. Search in Google Scholar

30. Brown J, O’Brien P, Marjoribanks J, Wyatt K. Selective serotonin re-uptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews [Internet] 2009 Apr [cited 2018 Jul 08];2. Available from: doi: 10.1002/14651858. CD001396.pub2.10.1002/14651858 Search in Google Scholar

31. Shah NR, Jones JB, Aperi J et al. Selective serotonin reup-take inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 2008; 111(5): 1175-1182.10.1097/AOG.0b013e31816fd73b267036418448752 Search in Google Scholar

eISSN:
2719-5384
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Vorklinische Medizin, Grundlagenmedizin, Immunologie, Klinische Medizin, andere